FIELD: pharmaceutics. SUBSTANCE: water-dispersible tablets are formed of granules having following composition, wt.-%: pharmaceutically active compound, 5-25; pharmaceutically acceptable swellable clay, 0.25-60; various additives and adjuvants, the balance. Active compound is selected from group consisting of analgetically active propionic acid derivative, tranquilizing benzodiazepine, antiviral nucleoside derivative, naphtoquinone compound active against protozan organisms, allopurinol, oxopurinol, anticonvulsively active 1,2,4-triazine derivative, trimethoprim and trimethoprim in combination with sulphomethoxazole. Swellable clay acts as dispersing agent and is contained inside granules constituting tablet. It takes only 3 min to disperse tablet in water. Dispersion thus-formed consists of particles having size below 710 mcm. It is preferable that active compound be acyclovir or lamotrygin. Swellable clay is selected from group consisting of attapulgite, smectite, bentonite or clay sold in market under trade name VEEGUM F. Tablet may be coated with film, and in this case it takes about 2 min to disperse it. EFFECT: effective method for producing quickly dispersible medicinal tablets. 44 cl, 16 tbl
Title |
Year |
Author |
Number |
METHOD OF SYNTHESIS OF 4-AMINO-2-(4-METHYLPIPERAZINE-1-YL)-5-(2,3,5-TRICHLOROPHENYL)- -PYRIMIDINE OR ITS ACID ADDITIVE SALT |
1989 |
- Ehlistehjr Ehjnsli Miller[Gb]
- Mal'Kol'M Stjuart Nobbz[Gb]
- Richard Martin Gajd[Gb]
- Majkl Dzhon Lich[Gb]
|
RU2079493C1 |
METHOD FOR TREATING AND/OR PROPHYLAXIS OF PROTOZOAN PARASITARY INFECTION, USE OF ATOVACUON AND PROGUANYL FOR PRODUCING MEDICINAL PREPARATION FOR TREATING PROTOZOAN INFECTIONS, COMBINATION OF ATOVACUON WITH PROGUANYL FOR TREATING PROTOZOAN INFECTIONS, USE OF SAID COMBINATION AND PHARMACEUTICAL PREPARATION |
1993 |
- Uinston Ehdvard Gatteridzh[Gb]
- Dehvid Brajan Ehshton Khatchinson[Gb]
- Viktorija S'Juzn Lehtter[Gb]
- Mehri Padni[Gb]
|
RU2108092C1 |
METHOD OF HEPATITIS B TREATMENT |
1992 |
- Fillip Allen Furman
- Dzhordzh Robert Pejnter Iii[Us]
|
RU2104700C1 |
METHOD OF SYNTHESIS OF ENANTIOMERIC COMPOUNDS OR THEIR DERIVATIVES |
1990 |
|
RU2068849C1 |
ENANTIOMERIC COMPOUNDS AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF |
1992 |
|
RU2091386C1 |
APPLICATION OF 5-ETHYNYLURACIL AS AN ACTIVATOR OF URACIL-REDUCTASE, PHARMACEUTICAL COMPOSITION, METHOD FOR ITS OBTAINING, PHARMACEUTICAL COMPOSITION FOR INCREASING THE ACTION OR DECREASING THE TOXICITY OF 5-FLUOURACIL |
1991 |
- Spektor Tomas
- Porter Dehvid Dzhon Timoti
- Rakhim Saad Dzhordzh
|
RU2194511C2 |
PYRIMIDINE DERIVATIVES, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION |
1989 |
- Ehlistehjr Ehjnsli Miller
- Mal'Kol'M Stjuart Nobbz
- Richard Martin Gajd
- Majkl Dzhon Lich
|
RU2121998C1 |
ATOVACON IN FORM OF PARTICLES, MICROFLUIDIZED ATOVACON PARTICLES, PHARMACEUTICAL COMPOSITION CONTAINING ATOVACON PARTICLES AND METHOD OF ITS PREPARING |
1993 |
|
RU2127585C1 |
N,N-DIMETHYL-2-(5-(2-OXO-1,3-OXAZOLIDINE-4-YL-METHYL)-1H-INDO- -LE-3-YL)-ETHYLAMINE, ITS PHYSIOLOGICALLY ACCEPTABLE SALT OR SOLVATE, METHOD OF ITS SYNTHESIS, DRUG USED AS AN AGONIST OF "5-HT-LIKE" RECEPTOR IN MAMMALS, METHOD OF DRUG AGENT PREPARING |
1991 |
- Alan Dunkan Robertson[Gb]
- Alan Piter Khill[Gb]
- Robert Cherl'Z Glen[Gb]
- Grehm Richard Martin[Gb]
|
RU2110517C1 |
ANTIVIRAL AGENT AND METHOD OF PREPARATION THEREOF |
2000 |
|
RU2160105C1 |